Novartis, Vertex ve Ipsen Maintain the Pace of Acquisitions in the Pharmaceutical Sector

Merger and acquisition (M&A) activities in the biopharmaceutical sector have accelerated significantly and show no signs of slowing down.

Particularly within the first six days of Temmuz, four major companies have announced important acquisition decisions to the public. These remarkable initiatives hold a massive financial volume potential…